ABT Stock Analysis: Buy, Sell, or Hold?
ABT - Abbott Laboratories
$105.70
0.09 (0.09%)
▲
5d:
+2.56%
30d:
+14.67%
90d:
+16.42%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Oct 14, 2026
Smart Money Distribution
None View Scanner →
Strength: 6.5/10
Get Alerted When ABT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ABT shows positive signals but monitor for confirmation. Market pricing in 0.1% growth. Moderate conviction.
💡 BUY OPPORTUNITY: ABT shows positive signals but monitor for confirmation. Market pricing in 0.1% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$147.47
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$91.56
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ABT is currently trading at $105.70, which is considered extended relative to its 30-day fair value range of $91.03 to $102.69. The stock's valuation (Forward PE: 17.4) is in line with its historical norms (17.4). At these levels, the market is pricing in 0.1% annual earnings growth.
Technical Outlook: Technically, ABT is in a downtrend. Immediate support is located at $99.34, while resistance sits at $110.04.
Market Sentiment: ABT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $118.42 (+12.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ABT is in a downtrend. Immediate support is located at $99.34, while resistance sits at $110.04.
Market Sentiment: ABT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $118.42 (+12.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$91.03 -
$102.69
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
62.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($118.42)
- BULLISH: Expecting earnings turnaround to 0.1% growth with 13.0% revenue growth
Trading Range Analysis
30-Day Trading Range
$91.03 -
$102.69
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$99.34
Resistance Level
$110.04
Current Trend
Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.44
Wall Street Target
$118.42
(+12.0%)
Revenue Growth (YoY)
13.0%
Earnings Growth (YoY)
-47.5%
Profit Margin
11.7%
Valuation Premium vs History
+0.1% premium
PE vs Historical
17.4 vs 17.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.1%
(market-implied from PE analysis)
1-Year Target
$105.81
(+0%)
2-Year Target
$105.91
(+0%)
3-Year Target
$106.02
(+0%)
3-Yr Target (if PE normalizes)
(PE: 17→17)
PE COMPRESSION
$105.80
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 9.9%)
$166.74
(+58%)
Base:
(SPY PE: 17.4, Growth: 9.9%)
$140.24
(+33%)
Bear:
(PE: 14.8, Growth: 9.9%)
$119.20
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 34.97 | Current EPS (TTM): $3.02
Bull Case
$232.34
(+120%)
Analyst growth 100.0%, PE expands to 38.5
Base Case
$211.22
(+100%)
Market implied 100.0%, PE stable at 35.0
Bear Case
$71.81
(-32%)
Severe decline -20.0%, PE contracts to 29.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 11:48 AM ET
Data refreshes hourly during market hours. Next update: 12:48 PM
Data refreshes hourly during market hours. Next update: 12:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABT showing a specific setup today?
Insider Activity (6 Months)
6
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Laura Friedman
SELL
2026-03-24
Ro Khanna
BUY
2026-03-23
Featured in Portfolios
ABT is a key holding in these high-performance investment strategies.
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 51 HOLD |
Advanced ABT Option Strategies
Professional options setups generated by AI based on today's ABT price and gamma walls.
